VRXA (Veraxa Biotech Holding AG) Beneish M-Score

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VRXA Veraxa Biotech Holding AG VRXA
6 GF Score
Price $1.50
! 3 Warning Signs
View Full Analysis

What is Veraxa Biotech Holding AG Beneish M-Score?

Veraxa Biotech Holding AG does not have enough data to calculate Beneish M-Score.

Veraxa Biotech Holding AG Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Veraxa Biotech Holding AG's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veraxa Biotech Holding AG Beneish M-Score Chart

Veraxa Biotech Holding AG Annual Data
Trend Dec23 Dec24 Dec25
Beneish M-Score
0.00 0.00 0.00

Veraxa Biotech Holding AG Quarterly Data
Jun24 Dec24 Jun25 Dec25
Beneish M-Score 0.00 0.00 0.00 0.00

VRXA vs KRRO, CNXU, NKTX: Beneish M-Score Comparison

For the Biotechnology subindustry, Veraxa Biotech Holding AG's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Veraxa Biotech Holding AG Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veraxa Biotech Holding AG's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Veraxa Biotech Holding AG's Beneish M-Score falls into.


VRXA
6GF Score
Veraxa Biotech Holding AG VRXA
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veraxa Biotech Holding AG Business Description

Other Exchanges J8L0:Germany
Address Talacker 35, Zurich, CHE, 8001
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
6GF Score

Get the complete analysis for VRXA

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.50
Price